Log in to save to my catalogue

Genomics to select treatment for patients with metastatic breast cancer

Genomics to select treatment for patients with metastatic breast cancer

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_03867787v1

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Cancer progression is driven in part by genomic alterations
1
. The genomic characterization of cancers has shown interpatient heterogeneity regarding driver alterations
2
, leading to the concept that generation of genomic profiling in patients with cancer could allow the selection of effective therapies
3
,
4
. Although DN...

Alternative Titles

Full title

Genomics to select treatment for patients with metastatic breast cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_hal_primary_oai_HAL_hal_03867787v1

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_03867787v1

Other Identifiers

ISSN

0028-0836

E-ISSN

1476-4687

DOI

10.1038/s41586-022-05068-3

How to access this item